Nitric Oxide Synthase and Breast Cancer: Role of TIMP-1 in NO-mediated Akt Activation
Lisa A. Ridnour(National Institutes of Health), David A. Wink(National Cancer Institute), Sharon A. Glynn(Ollscoil na Gaillimhe – University of Galway), Stefan Ambs(University of Maryland, Baltimore), Michael M. Lizardo(BC Cancer Agency), Harris G. Yfantis(University of Maryland, Baltimore), Tiffany H. Dorsey(Center for Cancer Research), Robert Y.S. Cheng(National Cancer Institute), Julie L. Heinecke(National Cancer Institute), Kimberly M. Barasch(National Cancer Institute), Harry B. Hines(United States Army Medical Research Institute of Infectious Diseases), Alisha N. Windhausen(National Cancer Institute), Christopher Switzer(Center for Cancer Research), Chand Khanna(Drug Discovery Laboratory (Norway)), Dong Hoon Lee(Korea University), Ernst E. Brueggemann(United States Army Medical Research Institute of Infectious Diseases)
Cited by 71
Related Papers
Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer
|Cancer Research|2008|708
The multifaceted roles of nitric oxide in cancer
|Carcinogenesis|1998|682
“NONOates” (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: Convenient nitric oxide dosage forms
|Methods in enzymology on CD-ROM/Methods in enzymology|1996|674